A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass (Q44367911)

2 December 2017

title

A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass (English)

1 reference

2 December 2017

0 references

1 reference

2 December 2017

David L S Morales

1 reference

2 December 2017

Mauricio J Garrido

1 reference

2 December 2017

John D Madigan

1 reference

2 December 2017

David N Helman

1 reference

2 December 2017

Joseph Faber

1 reference

2 December 2017

Donald W Landry

1 reference

2 December 2017

Mehmet C Oz

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

The Annals of Thoracic Surgery

2 December 2017

published in

1 reference

2 December 2017

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

926-930

1 reference

Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

Vasopressin deficiency contributes to the vasodilation of septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

Certain cardiovascular effects of vasopressin (Pitressin)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

Blood pressure in acute and chronic vasopressin excess: studies of malignant hypertension and the syndrome of inappropriate antidiuretic hormone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

Effect of vasopressin blockade on blood pressure regulation during hemorrhage in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

Role of vasopressin in blood pressure regulation during adrenal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

Vasopressin pressor hypersensitivity in vasodilatory septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

EFFECT OF HEMORRHAGIC SHOCK ON THE REACTIVITY OF RESISTANCE AND CAPACITANCE VESSELS AND ON CAPILLARY FILTRATION TRANSFER IN CAT SKELETAL MUSCLE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

Molecular pharmacology of V1a vasopressin receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

Arginine vasopressin inhibits interleukin-1β-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904408-9

10.1016/S0003-4975(02)04408-9

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference